UAE Business: Gilead Sciences expands regional footprint with new Dubai office – Gulf Digital News

UAE Business: Gilead Sciences expands regional footprint with new Dubai office – Gulf Digital News

Gilead Sciences, a US research-based biopharmaceutical company, has announced the opening of its new office in Dubai.

Headquartered in Foster City, California, the company focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza and Covid-19.

The launch of the new office comes as part of its efforts to grow its regional footprint and expand its portfolio across areas such as Covid-19 and oncology, said statement from Gilead Sciences.

The opening ceremony was attended by senior officials including Dr Amin Hussein Al Amiri, Assistant Under-Secretary for the Health Regulation Sector, Ministry of Health and Prevention; Helal Saeed Al Marri, Director-General of the Dubai Department of Economy and Tourism; Prof. Alawi Alsheikh-Ali, Deputy Director-General of Dubai Health Authority (DHA); Dr Younis Kazim, CEO of Dubai Healthcare Corporation and Dr. Ali Al Sayed, Director of the Pharmaceutical Services Department at DHA.

On the new office, Dr Jacopo Andreose, Senior VP (Intercontinental and Global Patient Solutions) said: "The pharmaceutical sector in the UAE is benefitting from a steady rise in population and net income and the roll-out of the mandatory health insurance scheme. The healthcare industry is marked by continued improvement and strategic investments in high-quality medical services by